A Large Skin Cancer Screening Quality Initiative: Description and First-Year Outcomes.
Ontology highlight
ABSTRACT: The lack of prospective randomized clinical trials demonstrating that full-body skin examination (FBSE) reduces melanoma morbidity or mortality has prompted an "I" rating from the United States Preventive Services Task Force for population-based skin cancer screening. More data on these screening programs are needed.To describe a skin cancer screening quality initiative in a large health care system and to determine if the intervention was associated with screening of a demographically higher-risk population than previous screening programs and if melanoma incidence and thickness differed in screened vs unscreened patients.This observational evaluation of a prospectively implemented quality initiative was conducted in a large health care system in western Pennsylvania (University of Pittsburgh Medical Center, UPMC) among adults seen in an office visit by a UPMC-employed primary care physician (PCP) in 2014.Implementation of a campaign promoting annual skin cancer screening by FBSE, including training of PCPs, promotion of the initiative to physicians and patients, and modification of the electronic health record (EHR) to include FBSE as a recommended preventive service for patients 35 years or older.Characteristics of screened and unscreened patients and melanomas detected among them.Of 333?735 adult patients seen in an office visit by PCPs in 2014, 53?196 patients (15.9% of the screen-eligible population) received an FBSE, and 280?539 did not. Screened patients were slightly older (median age, 60 vs 57 years; P?
SUBMITTER: Ferris LK
PROVIDER: S-EPMC5552417 | biostudies-literature | 2017 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA